Literature DB >> 3232715

Multichannel cochlear implantation in a patient with bilateral Mondini deformities.

H Silverstein1, E Smouha, N Morgan.   

Abstract

A 31-year-old man with bilateral Mondini dysplasia was successfully implanted with a Nucleus multichannel 22-electrode cochlear prosthesis. To our knowledge, this is the first report of multichannel cochlear implantation in a patient with Mondini dysplasia. The surgical procedure used to insert the device was uncomplicated. Although objective measurements demonstrated only slight improvement in most categories of the Iowa test battery, he has the ability to discriminate pure-tone frequency differences and environmental sounds. Subjectively, he was a satisfied implant user. The surgical feasibility of multichannel implantation in patients with Mondini dysplasia should open the door for improved speech recognition and tonal discrimination in this subset of patients.

Entities:  

Mesh:

Year:  1988        PMID: 3232715

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  4 in total

1.  What is a 'Mondini' and what difference does a name make?

Authors:  W W Lo
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  Audiological and Surgical Outcomes of Pediatric Cochlear Implantation in Mondini's Dysplasia: Our Experience.

Authors:  Abha Kumari; Senthil Vadivu Arumugam; Virender Malik; Sunil Goyal; Mohan Kameswaran
Journal:  J Int Adv Otol       Date:  2021-01       Impact factor: 1.017

Review 3.  The LAURA multichannel cochlear implant in a true Mondini dysplasia.

Authors:  S Janssens; P J Govaerts; J Casselman; W Van Rompaey; A Van Langenhove; T Somers; F E Offeciers
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

4.  The development of auditory skills in young children with Mondini dysplasia after cochlear implantation.

Authors:  Xueqing Chen; Fei Yan; Bo Liu; Sha Liu; Ying Kong; Jun Zheng; Yongxin Li; Shusheng Gong; Demin Han; Luo Zhang
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.